O'Kane Kieran
Chief Commercial Officer
O'Kane Kieran has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 23, 2026.
On the most recent filing, O'Kane Kieran is listed as Chief Commercial Officer at BIODESIX INC. Inside the rolling window, O'Kane Kieran reported no open-market purchases and 4 open-market sales totaling $15K in BDSX. The largest disclosed transaction in the window is a sale of 535 BDSX shares on Feb 23, 2026, worth $7K.
Companies traded
Other insiders at BDSX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$15K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has O'Kane Kieran made?
O'Kane Kieran has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does O'Kane Kieran trade?
O'Kane Kieran has filed SEC Form 4 disclosures for 1 company, including BDSX.
When was O'Kane Kieran's most recent SEC Form 4 filing?
O'Kane Kieran's most recent SEC Form 4 filing on Tracefour is dated Feb 23, 2026.
What is O'Kane Kieran's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, O'Kane Kieran is listed as Chief Commercial Officer.
What is O'Kane Kieran's total buy and sell value in the current window?
Inside the rolling retention window, O'Kane Kieran bought $0 and sold $15K based on SEC Form 4 filings.
What was O'Kane Kieran's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 535 BDSX shares on 2026-02-23, worth $7K, per SEC Form 4 filings.